Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diagnoz.me was an Israel-based digital health and diagnostics startup developing a home diagnostic kit for microbial infections. Its core product concept used a proprietary disposable unit to turn a standard smartphone into a medical-grade diagnostic microscope, enabling patients to analyze body-fluid samples at home and transmit results to physicians. The company appeared particularly focused on rapid home vaginal diagnostics and physician-directed treatment. Available company-directory sources classify the business as a private for-profit health diagnostics company founded in 2017 in Jerusalem. However, more recent business database records indicate the company ceased operations in 2019, and there is no clear evidence of an active commercial product launch or clinical-stage therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diagnoz.me.